Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Elekta AB ( ($SE:EKTA.B) ) has shared an announcement.
Elekta has created a new position of Vice Chair of the Board and appointed current board member and Audit Committee chair Tomas Eliasson to the role, effective immediately. Eliasson, who joined the board in 2023, brings extensive experience in finance, governance and strategy from global industrial and technology-driven companies, and his elevation is presented as a move to strengthen the board’s capacity to support Elekta’s long-term value creation and profitable growth as it continues to expand its role in precision radiation therapy and global cancer care.
The most recent analyst rating on ($SE:EKTA.B) stock is a Sell with a SEK52.00 price target. To see the full list of analyst forecasts on Elekta AB stock, see the SE:EKTA.B Stock Forecast page.
More about Elekta AB
Elekta is a Stockholm-headquartered leader in precision radiation therapy, developing technology and solutions to expand access to high-quality, cost-efficient cancer care worldwide. With around 4,500 employees and offices in more than 40 countries, the company collaborates closely with healthcare providers to deliver outcome-driven cancer treatment systems and services, and its shares are listed on Nasdaq Stockholm.
Average Trading Volume: 1,306,953
Technical Sentiment Signal: Hold
Current Market Cap: SEK22.96B
See more insights into EKTA.B stock on TipRanks’ Stock Analysis page.